RareCyte
High-Plex Spatial Proteomics at Clinical Research Scale
Seattle, United States · Founded 2006 · $74.7M raised
- Headquarters
- Seattle, Washington
- Employees
- 51–200
- Founded
- 2006
- Business Model
- B2B
- Website
- rarecyte.com
- Total Funding
- $74.7M
- Last Round
- $658K GrantJun 2025
- Rounds
- 5
About
RareCyte develops advanced spatial biology and liquid biopsy technologies that deliver the reliable data researchers need to accelerate biomarker development and advance precision biology at clinical scale. The Orion spatial proteomics platform delivers the multiplex depth, throughput, and reproducible data quality researchers need to advance biomarker programs. Designed for CTC monitoring in global clinical trials, the CyteFinder platform accurately and reproducibly phenotypes as few as 1 CTC per tube of blood. RareCyte also accelerates biomarker programs with custom assay development, clinical trial testing, and biomarker research services, and is a proven partner to over 100 biopharma and leading academic institutions.
Summary
RareCyte is a Biotech company based in Seattle, United States, founded in 2006. It has raised $74.7M in total across 5 rounds, most recently a $658K Grant round in Jun 2025. Investors include Arboretum Ventures, F-Prime Capital and HealthQuest Capital.
Tech & App Stack
8 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jun 2025
Sign up to see all 5 events
Funding: Series A through Grant. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Specialty pharmaceutical company
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/rarecyte"><img src="https://indexed.vc/api/badge/company/rarecyte" alt="RareCyte on Indexed.vc" width="260" height="76" /></a>